This compound, also known as Co(salen), is a coordination complex that has been extensively studied for its catalytic and magnetic properties. It is synthesized through the reaction of salicylaldehyde and ethylenediamine in the presence of cobalt(II) chloride. Co(salen) has been explored as a catalyst for various organic reactions, including oxidation, epoxidation, and ring-opening polymerization. Its magnetic properties have also attracted attention, particularly in the field of molecular magnetism. The study of Co(salen) is driven by its potential applications in catalysis, magnetic materials, and other areas of chemistry.'
| ID Source | ID |
|---|---|
| PubMed CID | 26517 |
| SCHEMBL ID | 510827 |
| MeSH ID | M0045100 |
| Synonym |
|---|
| nsc32965 |
| salcomin |
| cobalt, [[2,2'-[1,2-ethanediylbis[(nitrilo-.kappa.n)methylidyne]]bis(phenolato-.kappa.o]](2-)]-, (sp-4-2)- |
| 14167-18-1 |
| rd3-0171 |
| salcomine |
| cobaltous 2-[(e)-2-[(e)-(2-hydroxyphenyl)methyleneamino]ethyliminomethyl]phenol |
| n,n-ethylenebis(salicylideneiminato)cobalt(ii) |
| bis(salicylaldehyde)ethylenediimine cobalt(ii) |
| cobalt, n,n'-ethylenebis(salicylideneiminato)- |
| (n,n'-ethylenebis(salicylaldehyde iminato))cobalt(ii) |
| salicylaldehyde ethylenediimine cobalt |
| (ethylenebis(nitrilomethylidyne)-2,2'-diphenolato)cobalt(ii) |
| nsc-32965 |
| n,n'-bis(salicylidene)ethylenediiminocobalt(ii) |
| S0318 |
| n,n'-disalicylalethylenediamine cobalt(ii) |
| n2o9115ytk , |
| AKOS015914817 |
| SCHEMBL510827 |
| cobalt, ((.alpha.,.alpha.'-(ethylenedinitrilo)di-o-cresolato) (2-))- |
| salcomine [hsdb] |
| cobalt, ((2,2'-(1,2- ethanediylbis(nitrilomethylidyne))bis(phenolato))(2-)- n,n',o,o')-, (sp-4-2)- |
| cobalt, ((2,2'-(1,2-ethanediylbis((nitrilo- .kappa.n)methylidyne))bis(phenolato-.kappa.o))(2-))-, (sp-4-2)- |
| NPAQSKHBTMUERN-UHFFFAOYSA-L |
| DTXSID1065718 |
| cobalt(2+);2-[2-[(2-oxidophenyl)methylideneamino]ethyliminomethyl]phenolate |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.42) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||